Who owns Disc Medicine, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IRON from SEC Form 13F filings across 237 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 237 institutions disclosed 43.6M shares of Disc Medicine, Inc. worth $2.86B — about 112.1% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
237
13F holders
$2.86B
value, 2026 filers
112.1%
of shares outstanding (43.6M sh)
45
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of IRON's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 4.8M | $314.4M | 0.0% | 12.3% | -1.9% |
| 2 | BlackRock, Inc. | 2.5M | $165.8M | 0.0% | 6.5% | +2.6% |
| 3 | RA CAPITAL MANAGEMENT, L.P. | 2.5M | $160.4M | 1.6% | 6.3% | 0.0% |
| 4 | JPMORGAN CHASE & CO | 1.8M | $119.5M | 0.0% | 4.7% | -3.4% |
| 5 | WELLINGTON MANAGEMENT GROUP LLP | 1.8M | $115.0M | 0.0% | 4.5% | +0.9% |
| 6 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.7M | $108.4M | 0.0% | 4.3% | -11.7% |
| 7 | Vestal Point Capital, LP | 1.6M | $107.0M | 2.8% | 4.2% | +5.5% |
| 8 | STATE STREET CORP | 1.4M | $92.0M | 0.0% | 3.6% | -14.8% |
| 9 | Atlas Venture Life Science Advisors, LLC | 1.4M | $90.6M | 14.4% | 3.6% | -8.6% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 1.4M | $90.6M | 0.0% | 3.6% | +1.1% |
| 11 | TCG Crossover Management, LLC | 1.3M | $87.8M | 2.5% | 3.4% | 0.0% |
| 12 | Assenagon Asset Management S.A. | 1.1M | $73.3M | 0.1% | 2.9% | +191.4% |
| 13 | Opaleye Management Inc. | 1.1M | $71.7M | 8.1% | 2.8% | +28.1% |
| 14 | Logos Global Management LP | 1.0M | $66.4M | 3.6% | 2.6% | +16.0% |
| 15 | Woodline Partners LP | 958,281 | $62.7M | 0.2% | 2.5% | 0.0% |
| 16 | Frazier Life Sciences Management, L.P. | 934,852 | $61.2M | 1.5% | 2.4% | -31.0% |
| 17 | Siren, L.L.C. | 888,401 | $58.2M | 1.4% | 2.3% | 0.0% |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 797,727 | $52.2M | 0.0% | 2.1% | +1.0% |
| 19 | DEERFIELD MANAGEMENT COMPANY, L.P. | 657,000 | $43.0M | 0.7% | 1.7% | 0.0% |
| 20 | Saturn V Capital Management LP | 612,661 | $40.1M | 5.9% | 1.6% | +16.8% |
| 21 | Aberdeen Group plc | 597,841 | $39.1M | 0.1% | 1.5% | +36.4% |
| 22 | DIMENSIONAL FUND ADVISORS LP | 590,477 | $38.7M | 0.0% | 1.5% | +3.8% |
| 23 | TWO SIGMA INVESTMENTS, LP | 570,753 | $37.4M | 0.0% | 1.5% | +317.4% |
| 24 | Bellevue Group AG | 560,000 | $36.7M | 0.8% | 1.4% | 0.0% |
| 25 | ARMISTICE CAPITAL, LLC | 500,000 | $32.7M | 0.4% | 1.3% | +8.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.